O
Ocular Therapeutix, Inc.OCUL
Ocular Therapeutix, Inc. is an integrated biopharmaceutical company committed to redefining the retina experience. AXPAXLI (also known as OTX-TKI), Ocular's investigational product candidate for retinal disease, is an axitinib intravitreal hydrogel based on its ELUTYX proprietary bioresorbable hydrogel-based formulation.
US StocksHealthcareSmall CapBiotechnologyGrowth Stocks
OCUL の価格トレンド
Ocular Therapeutix, Inc. · TradingView フルチャート
NASDAQ:OCUL